Enlivex announces 1-for-15 reverse stock split

Castle Biosciences raises 2026 revenue guidance to $365M-$375M as TissueCypher volume trends toward 50%-52% growth

Murata Manufacturing GAAP EPS of ¥44.70, revenue of ¥502.26B; updates FY 2027 outlook

Siemens Healthineers Non-GAAP EPS of €0.70, revenue of €5.76B; updates FY 2026 outlook

Sumitomo GAAP EPS of ¥39.92, revenue of ¥1949.36B; reaffirms FY 2027 outlook